CANCER RES
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q1 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 肿瘤学 Oncology | SCIE | Q1 | 16/333 |
95.2%
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 肿瘤学 Oncology | SCIE | Q1 | 22/268 JCI 2.00 |
92.2%
|
CANCER RESEARCH is a premier peer-reviewed journal published by the American Association for Cancer Research (AACR). With an Impact Factor of 22.600 (2026) and consistently ranked in the JCR Q1 quartile, it stands as one of the most authoritative and highly cited journals in oncology and cancer biology. The journal’s scope encompasses the full spectrum of cancer research, from fundamental molecular and cellular biology to translational studies, preclinical therapeutics, epidemiology, and prevention. It publishes original research articles, comprehensive reviews, and brief reports that provide significant mechanistic insights into tumorigenesis, metastasis, tumor microenvironment, immunology, and drug resistance. The target audience includes academic researchers, clinical oncologists, pharmacologists, and biomedical scientists who require rigorous, cutting-edge findings to inform both basic discovery and clinical application. Notable features include a stringent peer-review process that prioritizes studies with high conceptual novelty and experimental depth, as well as the journal’s commitment to open access options through the AACR’s Open Access program, ensuring broad dissemination of critical findings. As a flagship title in the field, CANCER RESEARCH sets the benchmark for impactful cancer science, frequently publishing landmark studies that shape therapeutic strategies and diagnostic paradigms. Its enduring reputation, exceptional citation metrics, and association with the AACR make it an essential resource for advancing the understanding and treatment of cancer.